Recent Finacing
Recent Raise
Moximed develops and commercializes subcutaneous, implantable knee shock-absorbers (MISHA/KineSpring/Atlas) for minimally invasive outpatient unloading to reduce joint load and preserve native knees in mild-to-moderate osteoarthritis.
